SCHEMBL8563677

SCHEMBL8563677

CC1=C(C)C(=O)C(CCCCOc2ccc(CC3SC(=O)NC3=O)cc2)=C(C)C1=O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 11/20 0.55
HRH3 Q9Y5N1 1/20 0.54
CYP3A4 P08684 2/20 0.54
RXRA P19793 1/20 0.54
FFAR1 O14842 8/20 0.54
PPARA Q07869 2/20 0.54
MEN1 O00255 1/20 0.53
ALDH1A1 P00352 1/20 0.53
TP53 P04637 1/20 0.53
CYP1A2 P05177 1/20 0.53
MAPT P10636 1/20 0.53
HPGD P15428 1/20 0.53
ALOX15 P16050 1/20 0.53
TSHR P16473 1/20 0.53
KMT2A Q03164 1/20 0.53
HSD17B10 Q99714 1/20 0.53
TDP1 Q9NUW8 1/20 0.53
MPC2 O95563 2/20 0.48
CYP2C8 P10632 2/20 0.48
CYP2C9 P11712 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8562482 0.97 PPARG (0.56) PPARGHRH3CYP3A4RXRAFFAR1
SCHEMBL8565412 0.96 PPARG (0.55) PPARGHRH3CYP3A4RXRAFFAR1
SCHEMBL8564112 0.93 PPARG (0.60) PPARGHRH3CYP3A4RXRAFFAR1
SCHEMBL8570339 0.87 FFAR1 (0.63) PPARGHRH3CYP3A4RXRAFFAR1
SCHEMBL8564772 0.86 FFAR1 (0.62) PPARGHRH3CYP3A4RXRAFFAR1
SCHEMBL8564497 0.83 FFAR1 (0.48) PPARGHRH3CYP3A4RXRAFFAR1
SCHEMBL9570574 0.83 FFAR1 (0.69) PPARGHRH3CYP3A4RXRAFFAR1
SCHEMBL8957444 0.83 FFAR1 (0.69) PPARGHRH3CYP3A4RXRAFFAR1
SCHEMBL9570560 0.83 FFAR1 (0.69) PPARGHRH3CYP3A4RXRAFFAR1
SCHEMBL9570697 0.83 FFAR1 (0.69) PPARGHRH3CYP3A4RXRAFFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0549366-B1 Thiazolidine compounds containing a quinone group, their preparation and their therapeutic uses SANKYO CO (JP) 1998-04-15 EP claimed
US-5338855-A Treating diabetes or hyperlipemia SANKYO COMPANY, LIMITED (JP) 1994-08-16 US claimed
EP-0549366-A1 Thiazolidine compounds containing a quinone group, their preparation and their therapeutic uses Sankyo Company Limited (JP) 1993-06-30 EP claimed
EP-0549366-B1 Thiazolidine compounds containing a quinone group, their preparation and their therapeutic uses SANKYO CO (JP) 1998-04-15 EP disclosed
EP-0549365-B1 Thiazolidine compounds, their preparation and their therapeutic uses SANKYO CO (JP) 1995-08-09 EP disclosed
US-5338855-A Treating diabetes or hyperlipemia SANKYO COMPANY, LIMITED (JP) 1994-08-16 US disclosed
EP-0549366-A1 Thiazolidine compounds containing a quinone group, their preparation and their therapeutic uses Sankyo Company Limited (JP) 1993-06-30 EP disclosed
EP-0549365-A1 Thiazolidine compounds, their preparation and their therapeutic uses Sankyo Company Limited (JP) 1993-06-30 EP disclosed